MediPal Holdings Corporation (TYO:7459)

Market Cap	555.49B
Revenue (ttm)	3.71T
Net Income (ttm)	40.86B
Shares Out	205.74M
EPS (ttm)	196.46
PE Ratio	13.74
Forward PE	14.93
Dividend	64.00 (2.36%)
Ex-Dividend Date	Sep 29, 2025

Volume	75,600
Average Volume	405,730
Open	2,677.50
Previous Close	2,700.00
Day's Range	2,659.00 - 2,702.00
52-Week Range	2,156.00 - 2,721.50
Beta	-0.01
RSI	67.34
Earnings Date	Nov 5, 2025

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health products for...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,061
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7459

Financial Performance

In 2024, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.